MetaADEDB 2.0 @ LMMD
lepirudin
(FIBJDTSHOUXTKV-BRHMIFOHSA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CCC(=O)O)[C@H](CC)C)CCC(=O)O)CCC(=O)O)Cc1ccccc1)CC(=O)O)CC(=O)O)CC(=O)N)Cc1nc[nH]c1)CO)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC2=O)CCC(=O)N)CC(=O)N)CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](CC(C)C)N)Cc2ccc(cc2)O)CC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(C)C)CC(=O)N)CCC(=O)N)CO)CC(C)C)C(C)C)CCC(=O)O
Molecular Formula:
C287H440N80O111S6
Molecular Weight:
6979.420
Log P:
-10.1289
Hydrogen Bond Acceptor:
196
Hydrogen Bond Donor:
100
TPSA:
3258.92
CAS Number(s):
138068-37-8
Synonym(s)
1.
lepirudin
2.
1-Leu-2-Thr-63-desulfohirudin
3.
Aventis Brand Lepirudin
4.
HBW 023
5.
HBW-023
6.
Refludan
7.
Refludin
External Link(s)
MeSHC083544
PubChem Compound118856773
ChEBI142437
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypotensionFAERS: 9SIDER
US FAERS
2Medication ErrorFAERS: 7US FAERS
3No adverse eventFAERS: 7US FAERS
4Accidental overdoseFAERS: 6US FAERS
5OverdoseFAERS: 6US FAERS
6SepsisFAERS: 6SIDER
US FAERS
7Angina PectorisFAERS: 4US FAERS
8Deep Vein ThrombosisFAERS: 4US FAERS
9EpistaxisFAERS: 4SIDER
US FAERS
10InfectionFAERS: 4SIDER
US FAERS
11Low Cardiac Output SyndromeFAERS: 4US FAERS
12Abdominal PainFAERS: 3US FAERS
13Heparin-induced thrombocytopeniaFAERS: 3US FAERS
14ThrombocytopeniaFAERS: 3

View details

CTD
US FAERS
15Activated partial thromboplastin time abnormalFAERS: 2US FAERS
16AnuriaFAERS: 2US FAERS
17Brain DeathFAERS: 2US FAERS
18Cardiac ArrestFAERS: 2SIDER
US FAERS
19Cerebral InfarctionFAERS: 2US FAERS
20Chest PainFAERS: 2US FAERS
21Chest discomfortFAERS: 2US FAERS
22Depressed Level of ConsciousnessFAERS: 2US FAERS
23Drug clearance decreasedFAERS: 2US FAERS
24Drug specific antibody presentFAERS: 2US FAERS
25EmbolismFAERS: 2US FAERS
26GangreneFAERS: 212221676CTD
US FAERS
27Injection site extravasationFAERS: 2US FAERS
28PruritusFAERS: 2SIDER
US FAERS
29Pulmonary EmbolismFAERS: 212869178
16924578
CTD
SIDER
US FAERS
30Respiratory FailureFAERS: 2US FAERS
31Respiratory arrestFAERS: 2US FAERS
32Septic ShockFAERS: 2US FAERS
33ThrombosisFAERS: 2

View details

CTD
US FAERS
34TransplantFAERS: 2US FAERS
35UrticariaFAERS: 2SIDER
US FAERS
36Ventricular FibrillationFAERS: 2SIDER
US FAERS
37Abdominal sepsisFAERS: 1US FAERS
38Acute respiratory failureFAERS: 1US FAERS
39Air EmbolismFAERS: 1US FAERS
40Anticoagulation drug level above therapeuticFAERS: 1US FAERS
41Anticoagulation drug level below therapeuticFAERS: 1US FAERS
42AstheniaFAERS: 1US FAERS
43Atrial FibrillationFAERS: 1US FAERS
44Blood creatine increasedFAERS: 1US FAERS
45Blood creatinine abnormalFAERS: 1US FAERS
46Blood creatinine increasedFAERS: 1SIDER
US FAERS
47Bronchopulmonary DysplasiaFAERS: 1US FAERS
48Candida sepsisFAERS: 1US FAERS
49Catheter related infectionFAERS: 1US FAERS
50Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
51Disseminated Intravascular CoagulationFAERS: 112361208CTD
US FAERS
52Drug prescribing errorFAERS: 1US FAERS
53DysgeusiaFAERS: 1US FAERS
54ErythemaFAERS: 1US FAERS
55ExsanguinationFAERS: 1US FAERS
56FatigueFAERS: 1US FAERS
57General physical health deteriorationFAERS: 1US FAERS
58Implant site reactionFAERS: 1US FAERS
59Incorrect route of drug administrationFAERS: 1US FAERS
60Intercepted drug administration errorFAERS: 1US FAERS
61Intercepted medication errorFAERS: 1US FAERS
62LethargyFAERS: 1US FAERS
63MalaiseFAERS: 1US FAERS
64NauseaFAERS: 1SIDER
US FAERS
65Oropharyngeal swellingFAERS: 1US FAERS
66Pharmaceutical product complaintFAERS: 1US FAERS
67Procedural complicationFAERS: 1US FAERS
68Thrombosis in deviceFAERS: 1US FAERS
69Troponin increasedFAERS: 1US FAERS
70Unevaluable eventFAERS: 1US FAERS
71VomitingFAERS: 1SIDER
US FAERS
72Weight decreasedFAERS: 1US FAERS
73WheezingFAERS: 1US FAERS
74AbscessSIDER
75Acute myocardial infarctionSIDER
76AgitationSIDER
77Anaphylactic shockSIDER
78AngioedemaSIDER
79Arterial Occlusive Diseases9810286CTD
80Arterial thrombosisSIDER
81Aspartate Aminotransferase IncreasedSIDER
82BradycardiaSIDER
83BronchospasmSIDER
84ChillsSIDER
85Coronary Thrombosis17955717CTD
86DermatitisSIDER
87DyspepsiaSIDER
88EczemaSIDER
89Feeling abnormalSIDER
90FlushingSIDER
91GastritisSIDER
92Graft Occlusion, Vascular10209835CTD
93HeadacheSIDER
94Hemorrhage16553518CTD
95HypersensitivitySIDER
96Injection Site ReactionSIDER
97Injection site painSIDER
98PainSIDER
99Pericardial effusionSIDER
100PneumoniaSIDER
101Postoperative Hemorrhage10730738CTD
102ShockSIDER
103Skin necrosisSIDER
104StridorSIDER
105SuperinfectionSIDER
106ThrombophlebitisSIDER
107Vasodilation procedureSIDER
108VasodilationSIDER
109Venous Thrombosis12221676
19519692
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.